Zbigniew Michał Żuber (Zbigniew M Żuber, Zbigniew Żuber)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 24

Top Topics

Magnetic Resonance Imaging

Community Dwelling

Cardiovascular Risk Factors

Top Venues

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Rheumatology international

Polish archives of internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Wojciech Zaręba, Piotr Krawiec, Małgorzata Banaszkiewicz, Krzysztof Batko, Aleksandra Gołąb, Dariusz Plicner, Zbigniew Michał Żuber, Bogdan Batko
Newly developed cardiovascular risk factors in rheumatoid arthritis patients initiating biologic treatment. Reumatologia 61 (6) (2024)
Joanna Ożga, Elżbieta Mężyk, Wojciech Kmiecik, Wadim Wojciechowski, Zbigniew Michał Żuber
Magnetic resonance imaging of the musculoskeletal system in the diagnosis of rheumatic diseases in the pediatric population. Reumatologia 62 (3) (2024)
Wojciech Zaręba, Piotr Krawiec, Małgorzata Banaszkiewicz, Krzysztof Batko, Aleksandra Gołąb, Dariusz Plicner, Zbigniew Michał Żuber, Bogdan Batko
Newly developed cardiovascular risk factors in rheumatoid arthritis patients initiating biologic treatment. Reumatologia 61 (6) (2024)
Magdalena Krajewska-Włodarczyk, Mateusz Szeląg, Bogdan Batko, Zbigniew Michał Żuber, Michał Orleański, Krzysztof Podwójcic, Jakub Sowiński, Jakub Jopek, Maria Świderek, Michał Maluchnik, Marek Brzosko, Agata Śmiglewska, Brygida Kwiatkowska
Rheumatoid arthritis epidemiology: a nationwide study in Poland. Rheumatology international 44 (6) (2024)
Marcin Stajszczyk, Krzysztof Batko, Zbigniew Michał Żuber, Brygida Kwiatkowska, Magdalena Krajewska-Włodarczyk, Bogdan Batko
Charting the Etanercept Journey: Tracing Cost Dynamics in Poland's Off-Patent Market from Reference Drug Rivalry to Biosimilar Monopoly. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (4) (2024)
Wojciech Zaręba, Piotr Krawiec, Małgorzata Banaszkiewicz, Krzysztof Batko, Aleksandra Gołąb, Dariusz Plicner, Zbigniew Michał Żuber, Bogdan Batko
Newly developed cardiovascular risk factors in rheumatoid arthritis patients initiating biologic treatment. Reumatologia 61 (6) (2024)
Joanna Ożga, Elżbieta Mężyk, Wojciech Kmiecik, Wadim Wojciechowski, Zbigniew Michał Żuber
Coexisting Sacroiliac Arthritis and Chronic Nonbacterial Osteomyelitis in an Adolescent with Ehlers-Danlos Syndrome: A Case Report and Treatment Success. The American journal of case reports 25 (2024)
Brygida Kwiatkowska, Magdalena Krajewska-Włodarczyk, Bogdan Batko, Maria Maślińska, Marcin Stajszczyk, Jerzy Świerkot, Piotr Wiland, Zbigniew Michał Żuber, Krzysztof Tomasiewicz
COVID-19 prophylaxis, diagnostics, and treatment in patients with rheumatic diseases. The Polish experts panel opinion. Reumatologia 62 (1) (2024)
Magdalena Krajewska-Włodarczyk, Mateusz Szeląg, Bogdan Batko, Zbigniew Michał Żuber, Michał Orleański, Krzysztof Podwójcic, Jakub Sowiński, Jakub Jopek, Maria Świderek, Michał Maluchnik, Marek Brzosko, Agata Śmiglewska, Brygida Kwiatkowska
Rheumatoid arthritis epidemiology: a nationwide study in Poland. Rheumatology international (2024)
Magdalena Krajewska-Włodarczyk, Mateusz Szeląg, Bogdan Batko, Zbigniew Michał Żuber, Michał Orleański, Krzysztof Podwójcic, Jakub Sowiński, Jakub Jopek, Maria Świderek, Michał Maluchnik, Marek Brzosko, Agata Śmiglewska, Brygida Kwiatkowska
Rheumatoid arthritis epidemiology: a nationwide study in Poland. Rheumatology international 44 (6) (2024)
Brygida Kwiatkowska, Magdalena Krajewska-Włodarczyk, Bogdan Batko, Maria Maślińska, Marcin Stajszczyk, Jerzy Świerkot, Piotr Wiland, Zbigniew Michał Żuber, Krzysztof Tomasiewicz
COVID-19 prophylaxis, diagnostics, and treatment in patients with rheumatic diseases. The Polish experts panel opinion. Reumatologia 62 (1) (2024)
Marcin Stajszczyk, Brygida Kwiatkowska, Zbigniew Michał Żuber, Bogdan Batko
Access to biologics and Janus kinase inhibitors for treatment of rheumatic diseases in the biosimilars era in Poland: a nation-level study. Polish archives of internal medicine 134 (4) (2024)
Marcin Stajszczyk, Krzysztof Batko, Zbigniew Michał Żuber, Brygida Kwiatkowska, Magdalena Krajewska-Włodarczyk, Bogdan Batko
Charting the Etanercept Journey: Tracing Cost Dynamics in Poland's Off-Patent Market from Reference Drug Rivalry to Biosimilar Monopoly. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (4) (2024)
Marcin Stajszczyk, Krzysztof Batko, Zbigniew Michał Żuber, Brygida Kwiatkowska, Magdalena Krajewska-Włodarczyk, Bogdan Batko
Charting the Etanercept Journey: Tracing Cost Dynamics in Poland's Off-Patent Market from Reference Drug Rivalry to Biosimilar Monopoly. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (4) (2024)
Marcin Stajszczyk, Brygida Kwiatkowska, Zbigniew Michał Żuber, Bogdan Batko
Access to biologics and Janus kinase inhibitors for treatment of rheumatic diseases in the biosimilars era in Poland: a nation-level study. Polish archives of internal medicine 134 (4) (2024)
Marcin Stajszczyk, Brygida Kwiatkowska, Zbigniew Michał Żuber, Bogdan Batko
Access to biologics and Janus kinase inhibitors for treatment of rheumatic diseases in the biosimilars era in Poland: a nation-level study. Polish archives of internal medicine 134 (4) (2024)
Joanna Ożga, Elżbieta Mężyk, Wojciech Kmiecik, Wadim Wojciechowski, Zbigniew Michał Żuber
Magnetic resonance imaging of the musculoskeletal system in the diagnosis of rheumatic diseases in the pediatric population. Reumatologia 62 (3) (2024)
Wojciech Zaręba, Piotr Krawiec, Małgorzata Banaszkiewicz, Krzysztof Batko, Aleksandra Gołąb, Dariusz Plicner, Zbigniew Michał Żuber, Bogdan Batko
Newly developed cardiovascular risk factors in rheumatoid arthritis patients initiating biologic treatment. Reumatologia 61 (6) (2024)
Magdalena Krajewska-Włodarczyk, Mateusz Szeląg, Bogdan Batko, Zbigniew Michał Żuber, Michał Orleański, Krzysztof Podwójcic, Jakub Sowiński, Jakub Jopek, Maria Świderek, Michał Maluchnik, Marek Brzosko, Agata Śmiglewska, Brygida Kwiatkowska
Rheumatoid arthritis epidemiology: a nationwide study in Poland. Rheumatology international 44 (6) (2024)
Marcin Stajszczyk, Krzysztof Batko, Zbigniew Michał Żuber, Brygida Kwiatkowska, Magdalena Krajewska-Włodarczyk, Bogdan Batko
Charting the Etanercept Journey: Tracing Cost Dynamics in Poland's Off-Patent Market from Reference Drug Rivalry to Biosimilar Monopoly. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2024)
Marcin Stajszczyk, Krzysztof Batko, Zbigniew Michał Żuber, Brygida Kwiatkowska, Magdalena Krajewska-Włodarczyk, Bogdan Batko
Charting the Etanercept Journey: Tracing Cost Dynamics in Poland's Off-Patent Market from Reference Drug Rivalry to Biosimilar Monopoly. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (4) (2024)
Jakub Kuna, Zbigniew Michał Żuber, Grzegorz Chmielewski, Leszek Gromadziński, Magdalena Krajewska-Włodarczyk
Role of Distinct Macrophage Populations in the Development of Heart Failure in Macrophage Activation Syndrome. International journal of molecular sciences 23 (5) (2022)
Katarzyna Kasperkiewicz, Anna S Świerzko, Mateusz Michalski, Łukasz Eppa, Mikael Skurnik, Zbigniew Michał Żuber, Maciej Cedzyński
Antibodies Recognizing Yersinia enterocolitica Lipopolysaccharides of Various Chemotypes in Synovial Fluids From Patients With Juvenile Idiopathic Arthritis. Journal of immunology research 2022 (2022)
Zbigniew Michał Żuber, Aleksander Owczarek, Małgorzata Sobczyk, Agata Migas-Majoch, Dorota Turowska-Heydel, Agnieszka Sternal, Justyna Michalczak, Jerzy Chudek
Establishing percentile charts for hip joint capsule and synovial cavity thickness in apparently healthy children. Pediatric rheumatology online journal 15 (1) (2017)